Research Article

Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19

Table 2

Clinical characteristics stratified by serum CK trajectories.

Rising CK
n = 114 (8%)
Stable CK
n = 1180 (76%)
Fluctuating CK
n = 257 (16%)

Age, years50 ± 1253 ± 1450 ± 130.21
Male sex, n(%)88 (77)660 (55)201 (78)<0.001
Time since symptoms onset, days8 (5–11)8 (6–11)8 (6–10)0.89
DM, n(%)24 (21)303 (26)53 (21)0.15
HTN, n(%)29 (25)284 (24)53 (21)0.45
Obesity, n(%)50 (44)461 (39)122 (47)0.04
BMI, kg/m229.8 (27.5–32.5)28.7 (25.8–32.3)29.5 (27.1–33.0)0.007
Baseline PaO2/FiO2135 (85–164)231 (152–288)166 (104–256)<0.001
Baseline creatinine, mg/dL0.8 ± 0.20.8 ± 0.20.8 ± 0.21.00
Baseline Hb, g/dL16.2 (14.4–17.0)15.3 (14.2–16.4)15.6 (14.6–16.4)0.021
Leucocytes, cells/mcl11.8 (7.6–15.0)8.0 (5.9–11.4)9.5 (6.4–12.8)<0.001
Baseline LDH, IU/L (IQR)488 (380–648)309 (245–398)410 (306–538)<0.001
Baseline C-reactive protein, mg/dl19 (12–26)13 (7–20)15 (9–22)<0.001
Baseline ferritin, mg/dl800 (337–1268)489 (245–847)669 (333–1164)<0.001
Baseline Hs-cTnI, pg/mL7.9 (4.4–21.9)4.5 (3.0–7.4)5.7 (3.7–9.2)<0.001
Baseline fibrinogen, mg/dl731 (586–897)652 (482–770)668 (524–802)0.004
Baseline D-dimer, ng/dl966 (523–1825)733 (474–1150)781 (517–1620)<0.001
HA-AKI, n(%)24 (21)84 (7)18 (7)<0.001
HA-AKI stage
Stage 3, n(%)21 (18)14 (2)2 (1)<0.001
Hemodialysis requirement, n(%)7 (6)7 (1)0 (0)<0.001
Urine with hemoglobin + &<5 RBC (AKI onset)2 (2)6 (0.5)3 (1)0.98
Urine with hemoglobin + &<5 RBC (48 h after AKI)1 (0.8)5 (0.4)0 (0)0.98
HA-AKI evolution
Persistent AKI10 (9)27 (2)3 (1)<0.001
Rapid reversal AKI2 (2)29 (3)9 (4)0.54
Recovery AKI12 (11)28 (2)6 (2)<0,001
≥1 CK measurements ≥5000 IU/L, n(%)20 (18)00<0.001
Mechanical ventilation, n(%)110 (96)210 (18)109 (42)<0.001
Death, n (%)59 (52)114 (10)60 (23)<0.001

value shows a comparison between groups. Quantitative data are presented as median (interquartile range). BMI, body mass index; CK, creatine phosphokinase; HA-AKI, hospital-acquired acute kidney injury; HTN, hypertension; Hs-cTnI, high-sensitive cardiac troponin I; LDH, lactate dehydrogenase; DM, diabetes mellitus; RBC, red blood cell. Obesity is defined as having a BMI of ≥30 kg/m2.